Regen BioPharma Inc (RGBP)

[OTCShotCaller]

We're At A Major Cross Road - A Fundamental Shift in RGBP's Market Profile

I agree with your insight perspective

Based on consensus among Stockwitz posters this week it appears Eli Lilly is the #1 Pick for the $50 Million Partnership Acquisition Funding!

Seems reasonable to me seeing Lilly took a shot at co-developing an mRNA Cancer Vaccine with Curevac back in 2017 that cost them $100 Million up front for the partnership deal, but then it abruptly ended in June 2020 due to Curevac having faulty research data.

Lilly's $100M went up in smoke so no doubt they're likely to return to Regen where it all began via their collaborative efforts on NR2F6, the basis for an mRNA Cancer Vaccine. This is only speculation of course but it would make sense based on the history Lilly has with Regen which is undeniable!

Ironically Lilly shares IP claim on that molecule with Regen so it seems like a natural fit! Even one of Lilly's Senior Executives, Jean-Pierre Million, served as Chairman of Regen's Scientific Advisory Board some years ago for evaluating, developing, and licensing Regen's IP including NR2F6. By the Way Million owns at least 7M Shares of RGBP Stock which was disclosed in one of Regen's SEC filings.

So yes, I definitely agree with your perspective.

Based on all of Koos efforts throughout 2021, with over 40 SEC Filings, Patent re-activations, etc, he has succeeded in positioning RGBP for significant growth moving forward.

Any major partnership like the one currently pending for the $50M Acquisition should be the icing on the cake that moves the PPS IN AN UPWARD TREND. Additional developments like Regen's INDs entering Clinical Trials and any positive results of those trials is what is needed long term.

Be well and prosper...